Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Chromatography|November 17, 1993
Specific and sensitive high-performance liquid chromatographic method with fluorescence detection for measurement of lometrexol and its polyglutamates in biologic samplesJ R Muindi, C W Young, C ShihLeukemia|January 1, 1994
Clinical pharmacology of all-trans retinoic acidJ R Muindi, C W Young, R P WarrellLeukemia|November 1, 1994
Clinical pharmacology of all-trans retinoic acidJ R Muindi, C W Young, R P WarrellAnticancer Research|April 12, 2012
A prospective clinical trial of cholecalciferol 2000 IU/day in colorectal cancer patients: evidence of a chemotherapy-response interactionM G Fakih, C Andrews, J McMahon, et al.FEBS Letters|July 9, 1984
Hydroxyl radical production and DNA damage induced by anthracycline-iron complexJ R Muindi, B K Sinha, L Gianni, et al.The Journal of Biological Chemistry|August 25, 1987
5-Iminodaunomycin. An anthracycline with unique propertiesC E Myers, J R Muindi, J Zweier, et al.British Journal of Cancer|January 1, 1983
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studiesJ R Muindi, D R Newell, I E Smith, et al.Cancer Chemotherapy and Pharmacology|October 25, 2011
A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancerM G Fakih, A Groman, J McMahon, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
The comparative pharmacokinetics of pentamethylmelamine in man, rat, and mouseC J Rutty, D R Newell, J R Muindi, et al.Cancer Research|April 25, 1992
Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemiaJ R Muindi, S R Frankel, C Huselton, et al.Pageof 2